Computed tomography-derived cardiovascular risk markers, incident cardiovascular events, and all-cause mortality in nondiabetics: the Multi-Ethnic Study of Atherosclerosis

Aim We assess the improvement in discrimination afforded by the addition of the computed tomography risk markers thoracic aorta calcium (TAC), aortic valve calcification (AVC), mitral annular calcification (MAC), pericardial adipose tissue volume (PAT), and liver attenuation (LA) to the Framingham risk score (FRS) + coronary artery calcium (CAC) for incident coronary heart disease (CHD) and incident cerebrovascular disease (CVD) in a multiethnic cohort. Methods and results A total of 5745 participants were enrolled, with 2710 at intermediate Framingham risk, 210 CVD events, and 155 CHD events). Over 9 years of follow up, 251 had adjudicated CHD, 346 had CVD events, and 321 died. The data were analysed using Cox proportional hazard, receiver operator curve (ROC), and net reclassification improvement (NRI) analyses. In the whole cohort and also when the analysis was restricted to only the intermediate-risk participants, CAC, TAC, AVC, and MAC were all significantly associated with incident CVD, incident CHD, and mortality, and CAC had the strongest association. When added to the FRS, CAC had the highest area under the curve (AUC) for the prediction of incident CVD and incident CHD; LA had the least. The addition of TAC, AVC, MAC, PAT, and LA to FRS + CAC all resulted in a significant reduction in AUC for incident CHD (0.712 vs. 0.646, 0.655, 0.652, 0.648, and 0.569; all p < 0.01, respectively) in participants with intermediate FRS. The addition of CAC to FRS resulted in an NRI of 0.547 for incident CHD in the intermediate-risk group. The NRI when TAC, AVC, MAC, PAT, and LA were added to FRS + CAC were 0.024, 0.026, 0.019, 0.012, and 0.012, respectively, for incident CHD in the intermediate-risk group. Similar results were obtained for incident CVD in the intermediate-risk group and also when the whole cohort was used instead of the intermediate FRS group. Conclusions The addition of CAC to the FRS provides superior discrimination especially in intermediate-risk individuals compared with the addition of TAC, AVC, MAC, PAT, or LA for incident CVD and incident CHD. Compared with FRS + CAC, the addition of TAC, AVC, MAC, PAT, or LA individually to FRS + CAC worsens the discrimination for incident CVD and incident CHD. These risk markers are unlikely to be useful for improving cardiovascular risk prediction.

[1]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.

[2]  R. Kronmal,et al.  Multi-Ethnic Study of Atherosclerosis: objectives and design. , 2002, American journal of epidemiology.

[3]  D. Goff,et al.  Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals. , 2012, JAMA.

[4]  S. Achenbach,et al.  Cardiac computed tomography--evidence, limitations and clinical application. , 2012, Heart, lung & circulation.

[5]  D. Hosmer,et al.  A Simplified Method of Calculating an Overall Goodness-of-Fit Test for the Cox Proportional Hazards Model , 1998, Lifetime data analysis.

[6]  N. Sattar,et al.  Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease: A narrative review and clinical perspective of prospective data , 2010, Hepatology.

[7]  P. Høilund-Carlsen,et al.  Discrepancy between coronary artery calcium score and HeartScore in middle-aged Danes: the DanRisk study , 2012, European journal of preventive cardiology.

[8]  M. Pencina,et al.  Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation , 2004, Statistics in medicine.

[9]  R. Detrano,et al.  Calcified coronary artery plaque measurement with cardiac CT in population-based studies: standardized protocol of Multi-Ethnic Study of Atherosclerosis (MESA) and Coronary Artery Risk Development in Young Adults (CARDIA) study. , 2005, Radiology.

[10]  A. Gupta,et al.  Mesa , 2016, Communications of the ACM.

[11]  J. Sauver,et al.  The Framingham risk score and heart disease in nonalcoholic fatty liver disease , 2012, Liver international : official journal of the International Association for the Study of the Liver.

[12]  Michael J. Pencina,et al.  Statistical methods for assessment of added usefulness of new biomarkers , 2010, Clinical chemistry and laboratory medicine.

[13]  P. Greenland,et al.  Coronary artery calcium score and risk classification for coronary heart disease prediction. , 2010, JAMA.

[14]  Moyses Szklo,et al.  The association of pericardial fat with incident coronary heart disease: the Multi-Ethnic Study of Atherosclerosis (MESA). , 2009, The American journal of clinical nutrition.

[15]  R. Kronmal,et al.  Reproducibility of CT measurements of aortic valve calcification, mitral annulus calcification, and aortic wall calcification in the multi-ethnic study of atherosclerosis. , 2006, Academic radiology.

[16]  D. Levy,et al.  Mitral annular calcification and the risk of stroke in an elderly cohort. , 1992, The New England journal of medicine.

[17]  A. Hofman,et al.  Evaluation of Newer Risk Markers for Coronary Heart Disease Risk Classification , 2012, Annals of Internal Medicine.

[18]  David M. Herrington,et al.  Predictive Value of Brachial Flow-Mediated Dilation for Incident Cardiovascular Events in a Population-Based Study: The Multi-Ethnic Study of Atherosclerosis , 2009, Circulation.

[19]  E. DeLong,et al.  Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. , 1988, Biometrics.

[20]  R. Kronmal,et al.  Thoracic aortic calcification and coronary heart disease events: the multi-ethnic study of atherosclerosis (MESA). , 2011, Atherosclerosis.

[21]  B. Kaplan Coronary Artery Calcification Screening: Estimated Radiation Dose and Cancer Risk , 2010 .

[22]  M. Klapholz,et al.  Optimizing primary PCI beyond "door to intervention time"--are we there yet? , 2010, Cardiovascular revascularization medicine : including molecular interventions.

[23]  Dong Li,et al.  Computed tomography scans in the evaluation of fatty liver disease in a population based study: the multi-ethnic study of atherosclerosis. , 2012, Academic radiology.

[24]  R. D'Agostino,et al.  Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. , 2001, JAMA.